Request A Demo

Author: admin

Opto-Acoustic Imaging Leader Seno Medical Instruments Announces Recipient of Its 8th Annual Best Paper Award during the SPIE Annual Conference

-2017 award recognizes a novel optical imaging modality that provides high molecular contrast of important biomarkers throughout the body – SAN ANTONIO, January 30, 2018 – Seno Medical Instruments, Inc. (Seno Medical), the leader in new technology for breast cancer diagnosis using opto-acoustic (OA/US) imaging to differentiate benign from malignant masses, today announced the winner […]

Seno Medical Instruments Announces New Data Demonstrating That Imagio™ Opto-Acoustic Breast Imaging System Delivers Critical Diagnostic and Prognostic Information About Tumor Subtypes

–  Prospective clinical study presented at the San Antonio Breast Cancer Symposium suggests Imagio findings may help clinicians tailor patient treatment regimens – –  Functional Imaging provides important information about the growth and location of blood vessels around breast masses as compared to anatomical imaging – SAN ANTONIO, December 8, 2017 – Seno Medical Instruments, Inc. (Seno […]

Seno Medical Instruments’ Imagio™ Opto-Acoustic Breast Imaging System Demonstrates Ability to Downgrade Risk Classification of Benign Breast Masses in a Prospective European Clinical Trial

CHICAGO, November 28, 2017 – Seno Medical Instruments, Inc. (Seno Medical), the leader in new technology for breast cancer diagnosis using optoacoustic (OA/US) imaging to differentiate benign from malignant masses, today announced clinical data demonstrating that its Imagio™ breast imaging system effectively downgraded the risk classification of benign breast masses and upgraded the risk classification of malignant […]

Pivotal Trial Data Support Potential of Seno Medical Instruments’ Imagio™ Opto-Acoustic Breast Imaging System in Reducing False Positive Breast Examinations and Benign Biopsies

Results Presented in a High Impact Clinical Trial Session at the Radiology Society of North America (RSNA) Annual Meeting CHICAGO, November 27, 2017 – Seno Medical Instruments, Inc. (Seno Medical), the leader in new technology for breast cancer diagnosis using opto-acoustic ultrasound (OA/US) imaging to differentiate benign from malignant masses, today announced positive data from PIONEER, […]

Pivotal Trial Data Support Potential of Seno Medical Instruments’ Imagio™ Opto-Acoustic Breast Imaging System in Reducing False Positive Breast Examinations and Benign Biopsies

Results Presented in a High Impact Clinical Trial Session at the Radiology Society of North America (RSNA) Annual Meeting CHICAGO, November 27, 2017 – Seno Medical Instruments, Inc. (Seno Medical), the leader in new technology for breast cancer diagnosis using opto-acoustic ultrasound (OA/US) imaging to differentiate benign from malignant masses, today announced positive data from PIONEER, […]

Seno Medical Instruments Investigator Speaking to Opto-Acoustic Breast Imaging as a Strong Predictor of Malignancy

Results Presented at the American Roentgen Ray Society (ARRS) Annual Meeting San Antonio, May 10, 2017 – Seno Medical Instruments, Inc. (Seno Medical), the leader in new technology for breast cancer diagnosis, is using opto-acoustic (OA/US) imaging to differentiate benign from malignant masses. Seno Medical announced that its Imagio™ breast imaging system results correlate with the histopathological findings […]

Seno Medical Instruments Appoints Ann Waterhouse as VP, Quality Assurance and Regulatory Affairs

SAN ANTONIO, April 24, 2017 /PRNewswire/ — Seno Medical Instruments, Inc. (Seno Medical), the leader in improving the process of diagnosing breast cancer through the development of an opto-acoustic (OA/US) imaging device, today announced the appointment of Ann Waterhouse as Vice President of Quality Assurance and Regulatory Affairs. Ms. Waterhouse previously served as the Director of […]